Compare APhA vs ASHP Midyear
| 8.7 APhA | 9.7 ASHP Midyear | |
|---|---|---|
| Score | ||
| Buzzbox Score | 8.7 (Excellent) | 9.7 (Exceptional) |
| Event Details | ||
| Dates | March 27-30, 2026 | December 6-9, 2026 (Exhibits: December 7-9) |
| Location | Los Angeles, CA (Los Angeles Convention Center) | Orlando, FL (Orange County Convention Center) |
| Scale | large | mega |
| Audience | ||
| Attendees | 5,000 | 20,000 |
| Exhibitors | — | — |
| Purchasing authority | ~65% | ~65% |
| Effective buyers | 3,250 | 13,000 |
| Costs | ||
| $/sqft | $42 | $51 |
| 10×10 space | $4,200 | $5,100 |
| All-in estimate | $7,500 – $14,000 | $10,000 – $20,000 |
| Cost per buyer | $3.31 | $1.15 |
Why exhibit at APhA
The premier meeting for community and ambulatory care pharmacists, featuring pharmacy owners and managers who make independent purchasing decisions for their practices. Three complimentary full registrations per booth ($3,000 value) offsets the booth cost significantly. Strong if you sell pharmacy software, point-of-care testing, or immunization supplies.
Why exhibit at ASHP Midyear
The largest pharmacy-specific meeting in the world, with 20,000+ attendees and a 28:1 attendee-to-exhibitor ratio that ensures strong foot traffic. Pharmacy directors and clinical pharmacists who influence formulary decisions, medication management systems, and compounding equipment purchases are well-represented. If you sell to pharmacy departments, this is the must-attend show.
Why skip APhA
If your target buyer is hospital pharmacy, ASHP Midyear is the better venue (4x the audience, hospital-system focus). APhA's student-heavy attendance means lower purchasing authority density compared to shows with mainly practicing pharmacists. Community pharmacy is a shrinking market segment.
Why skip ASHP Midyear
Heavy student and resident presence (Residency Showcase is a major feature) dilutes the purchasing-authority density. Premium pricing at $51/sqft and 700 exhibitors mean your booth needs to stand out. If your product targets physicians or nurses rather than pharmacists, this is the wrong audience.